Calamos Advisors LLC Buys 944 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Calamos Advisors LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.8% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 113,164 shares of the medical equipment provider's stock after buying an additional 944 shares during the period. Calamos Advisors LLC's holdings in Intuitive Surgical were worth $56,047,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Norges Bank bought a new position in Intuitive Surgical in the fourth quarter worth approximately $2,401,493,000. GAMMA Investing LLC lifted its holdings in shares of Intuitive Surgical by 54,010.7% in the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock worth $14,999,630,000 after purchasing an additional 3,022,979 shares in the last quarter. Capital Research Global Investors lifted its holdings in shares of Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after purchasing an additional 687,906 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter worth $313,769,000. Finally, Northern Trust Corp lifted its holdings in shares of Intuitive Surgical by 15.8% in the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after purchasing an additional 494,496 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

ISRG stock traded up $3.14 during mid-day trading on Friday, hitting $543.74. The company had a trading volume of 704,815 shares, compared to its average volume of 1,672,707. The firm has a market cap of $194.89 billion, a PE ratio of 79.73, a price-to-earnings-growth ratio of 5.78 and a beta of 1.64. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00. The stock's fifty day moving average price is $537.11 and its two-hundred day moving average price is $536.83.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same quarter in the previous year, the firm posted $1.50 EPS. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of the business's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president directly owned 907 shares in the company, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the business's stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the sale, the executive vice president directly owned 5,224 shares in the company, valued at approximately $2,695,113.84. This trade represents a 3.47% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research firms have weighed in on ISRG. Truist Financial dropped their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Piper Sandler dropped their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the company a "buy" rating in a report on Monday, April 14th. Royal Bank Of Canada dropped their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Finally, Citigroup restated a "buy" rating and set a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.